ExploreWatchlistsPricing
  1. US-listed companies
  2. Jaguar Health, Inc.
  3. Financials
  4. EBITDA margin (%)

Jaguar Health, Inc. (JAGX)

Market cap
$28.25M
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Dec 31, 2025-382.2+54.42%
Dec 31, 2024-247.5-8.76%
Dec 31, 2022-271.3+2.16%
Dec 31, 2020-265.5-43.64%
Dec 31, 2019-471.2-29.48%
Dec 31, 2018-668.1-13.44%
Dec 31, 2017-771.9-91.93%
Dec 31, 2016-9,566.3+98.69%
Dec 31, 2015-4,814.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat